USING PAIN TOLERABILITY THRESHOLDS TO CHARACTERIZE CLINICALLY MEANINGFUL TREATMENT OUTCOMES IN KNEE OSTEOARTHRITIS: POST HOC ANALYSIS OF A PHASE 2B TRIAL OF INTRA-ARTICULAR LORECIV... von Markman, J.D., Bennett, H., Kennedy, S., Tambiah, J.R., Swearingen, C.J., Gewandter, J.S.

Volltext

OA14.06 Divarasib Single-Agent Long-Term Follow-up and Atezolizumab Combination Treatment in Patients with KRAS G12C-Positive NSCLC von Sacher, A., Miller, W.H., Paz-Ares, L., Ahn, M.-J., Patel, M., Dziadziuszko, R., Santoro, A., Luo, J., Markman, B., Freres, P., Van Dongen, M., Desai, J., Bowyer, S., Cervantes, A., Mourão Dias, J., Falcon, A., Krebs, M.G., Laurie, S., Prenen, H., Perets, R., Massarelli, E., Kim, S.H., de Miguel, M., Deva, S., Garralda, E., Medina, L., Guedes, J.D., Siena, S., Guren, T., Fernandez, E., Latten Jansen, L., De Cassia Costamilan, R., Choi, Y., Mandlekar, S., Lin, M.T., Yau, K.K., Chang, J., Royer-Joo, S., Jun, T., Dharia, N.V., Schutzman, J.L., Lorusso, P.

Volltext